Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells

Acta Biomaterialia

Volumn 7, Issue 11, 2011, Pages 4029-4036

  Sokolova, V ^a   Knuschke, T ^b   Buer, J ^b   Westendorf, A M ^b   Epple, M ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Calcium phosphate; Cell activation; Dendritic cells; Nanoparticles; Oligonucleotides

Indexed keywords

ANTIGENS; CALCIUM PHOSPHATE; CHEMICAL ACTIVATION; CYTOLOGY; OLIGONUCLEOTIDES; PURIFICATION; T-CELLS;

CALCIUM PHOSPHATE NANOPARTICLES; CELL ACTIVATION; CELL-BE; CELL/B.E; CELL/BE; DENDRITIC CELL; DENDRITICS; QUANTITATIVE DETERMINATIONS; RECEPTOR LIGANDS; TOLL-LIKE RECEPTORS;

NANOPARTICLES;

ANTIGEN; CALCIUM; CALCIUM PHOSPHATE; CYTOKINE; HEMAGGLUTININ; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NANOPARTICLE; OLIGONUCLEOTIDE; PEPTIDE; PHOSPHATE; POLYINOSINIC POLYCYTIDYLIC ACID; T LYMPHOCYTE ANTIGEN; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; ULTRACENTRIFUGATION; ULTRASOUND; ULTRAVIOLET SPECTROSCOPY; UPREGULATION;

EID: 80053568565     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.07.010     Document Type: Article

References (26)

1. S.V. Dorozhkin, and M. Epple Biological and medical significance of calcium phosphates Angew Chem Int Ed 41 2002 3130 3146 (Pubitemid 35021275)
2. M. Bohner Silicon-substituted calcium phosphates - A critical view Biomaterials 30 2009 6403 6406
3. V. Sokolova, and M. Epple Inorganic nanoparticles as carriers of nucleic acids into cells Angew Chem Int Ed 47 2008 1382 1395
4. S. Neumann, A. Kovtun, I.D. Dietzel, M. Epple, and R. Heumann The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection Biomaterials 30 2009 6794 6802
5. M. Urabe, A. Kume, K. Tobita, and K. Ozawa DNA/calcium phosphate precipitates mixed with medium are stable and maintain high transfection efficiency Anal Biochem 278 2000 91 92 (Pubitemid 30069075)
6. M. Jordan, and F. Wurm Transfection of adherent and suspended cells by calcium phosphate Methods 33 2004 136 143 (Pubitemid 38569658)
7. S. Bisht, G. Bhakta, S. Mitra, and A. Maitra PDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery Int J Pharm 288 2005 157 168 (Pubitemid 39656464)
8. M. Epple, K. Ganesan, R. Heumann, J. Klesing, A. Kovtun, and S. Neumann Application of calcium phosphate nanoparticles in biomedicine J Mater Chem 20 2010 18 23
9. V.V. Sokolova, I. Radtke, R. Heumann, and M. Epple Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles Biomaterials 27 2006 3147 3153 (Pubitemid 43247588)
10. V. Sokolova, A. Kovtun, O. Prymak, W. Meyer-Zaika, E.A. Kubareva, and E.A. Romanova Functionalisation of calcium phosphate nanoparticles by oligonucleotides and their application to gene silencing J Mater Chem 17 2007 721 727
11. J. Schwiertz, A. Wiehe, S. Gräfe, B. Gitter, and M. Epple Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria Biomaterials 30 2009 3324 3331
12. V. Sokolova, T. Knuschke, A. Kovtun, J. Buer, M. Epple, and A.M. Westendorf The use of calcium phosphate nanoparticles encapsulating toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T-cell activation Biomaterials 31 2010 5627 5633
13. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252 (Pubitemid 28155090)
14. O. Schulz, S.S. Diebold, M. Chen, T.I. Näslund, M.A. Nolte, and L. Alexopoulou Toll-like receptor 3 promotes cross-priming to virus-infected cells Nature 433 2005 887 892 (Pubitemid 40314900)
15. R.M. Verdijk, T. Mutis, B. Esendam, J. Kamp, C.J. Melief, and A. Brand Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells J Immunol 163 1999 57 61 (Pubitemid 29295824)
16. W. Byrd, A. de Lorimier, Z.-R. Zheng, and F.J. Cassels Microencapsulated subunit vaccine approach to enterotoxigenic Escherichia coli and other mucosal pathogens Adv Drug Del 57 2005 1362 1380 (Pubitemid 40791116)
17. S.T. Reddy, M.A. Swartz, and J.A. Hubbell Targeting dendritic cells with biomaterials: developing the next generation of vaccines Trends Immunol 12 2006 573 579 (Pubitemid 44708833)
18. M. Diwan, M. Tafaghodi, and J. Samuel Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres J Contr Rel 85 2002 247 262 (Pubitemid 35449468)
19. G. Chikh, S.D. de Jong, L. Sekirov, S.G. Raney, M. Kazem, and K.D. Wilson Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles Internat Immunol 21 2009 757 767
20. Y. Suzuki, D. Wakita, K. Chamoto, Y. Narita, T. Tsuji, and T. Takeshima Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity Cancer Res 64 2004 8754 8760 (Pubitemid 39552093)
21. S.K. Datta, H.J. Cho, K. Takabayashi, A.A. Horner, and E. Raz Antigen-immunostimulatory oligonucleotide conjugates (AIC): mechanisms and applications Immunol Rev 199 2004 217 226 (Pubitemid 38736774)
22. V. Jérôme, A. Graser, R. Müller, R.E. Kontermann, and A. Konur Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant J Immunother 29 2006 294 305 (Pubitemid 44297297)
23. G. Kaiser-Schulz, A. Heit, L. Quintanilla-Martinez, F. Hammerschmidt, S. Hess, and L. Jennen Polylactide-coglycolide microspheres co-encapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T-cell responses J Immunol 179 2007 2797 2807
24. K. Zwiorek, C. Bourquin, J. Battiany, G. Winter, S. Endres, and G. Hartmann Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides Pharm Res 25 2008 551 562 (Pubitemid 351357729)
25. K. Fearon, J.D. Marshall, C. Abbate, S. Subramanian, P. Yee, and J. Gregorio A minimal human immunostimulatory CpG motif that potently induces IFN-gamma and IFN-alpha production Eur J Immunol 33 2003 2114 2122 (Pubitemid 37010028)
26. J. Kirberg, A. Baron, S. Jakob, A. Rolink, K. Karjalainen, and H. von Boehmer Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor J Exp Med 180 1994 25 34 (Pubitemid 24181052)